Chemours lowers adjusted EBITDA and annual revenue growth guidance
CC Chemours Company
$13.29 -0.45%
View chart & analysis → - 1Chemours lowered its adjusted EBITDA guidance to $775 million - $825 million.
- 2Management stated that the fixed aftermarket market decreased by approximately 25% year-over-year.
- 3Performance Solutions grew by 8%.
So what's the key point?
Chemours has lowered its profit outlook. This means earnings may decrease as the parts replacement market has shrunk by about 25 percent.
Source Earnings Whispers · View original ↗
Nothing hidden: past picks and how they did against the S&P 500.